Amounts of LL-37-mtDNA complex increased in atherosclerotic plasma and plaques, resisted DNase II degradation, and escaped from autophagic recognition in atherosclerosis [26], indicating that CAMP might induce atherosclerosis to increase the risk of CHD. This evidence concerns the gene CAMP and atherosclerosis.